Giant Biogene Holding Co., Ltd.
2367
Rang in Aktien
#5025
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Aktienkurs
$2.67
Marktkapitalisierung
$2.84B
Veränderung (1 Tag)
-6.09%
Veränderung (1 Jahr)
-46.20%
Land
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Kategorie
Consumer Defensive
P/B-Verhältnis für Giant Biogene Holding Co., Ltd. (2367)
P/B-Verhältnis zum October 2026 TTM: 2.00
Laut den neuesten Finanzberichten und dem Aktienkurs von Giant Biogene Holding Co., Ltd. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 2.00. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 6.60.
P/B-Verlauf für Giant Biogene Holding Co., Ltd. von 2019 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 2.00 | -37.21% |
| 2025 | 3.19 | -51.68% |
| 2024 | 6.60 | -9.00% |
| 2023 | 7.25 | -29.02% |
| 2022 | 10.22 | -50.98% |
| 2021 | 20.85 | -57.14% |
| 2020 | 48.63 | 136.00% |
| 2019 | 20.61 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| 6.9837 | 248.68% |
US
|
|
| 6.3772 | 218.40% |
FR
|
|
| 315.2455 | 15,639.45% |
US
|
|
| 9.0934 | 354.01% |
IN
|
|
| 9.8894 | 393.75% |
US
|
